0000926326FALSEDecember 312020Q1P5YP5YP5YP1YP1YP1Y00009263262020-01-012020-03-31xbrli:shares00009263262020-05-01iso4217:USD00009263262020-03-3100009263262019-12-31iso4217:USDxbrli:shares0000926326us-gaap:ProductMember2020-01-012020-03-310000926326us-gaap:ProductMember2019-01-012019-03-310000926326us-gaap:ServiceMember2020-01-012020-03-310000926326us-gaap:ServiceMember2019-01-012019-03-3100009263262019-01-012019-03-310000926326us-gaap:CommonStockMember2019-12-310000926326us-gaap:TreasuryStockMember2019-12-310000926326us-gaap:AdditionalPaidInCapitalMember2019-12-310000926326us-gaap:RetainedEarningsMember2019-12-310000926326us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310000926326us-gaap:RetainedEarningsMember2020-01-012020-03-310000926326us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310000926326us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310000926326us-gaap:CommonStockMember2020-01-012020-03-310000926326us-gaap:AccountingStandardsUpdate201613Memberus-gaap:RetainedEarningsMember2020-01-010000926326us-gaap:AccountingStandardsUpdate201613Member2020-01-010000926326us-gaap:CommonStockMember2020-03-310000926326us-gaap:TreasuryStockMember2020-03-310000926326us-gaap:AdditionalPaidInCapitalMember2020-03-310000926326us-gaap:RetainedEarningsMember2020-03-310000926326us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310000926326us-gaap:CommonStockMember2018-12-310000926326us-gaap:TreasuryStockMember2018-12-310000926326us-gaap:AdditionalPaidInCapitalMember2018-12-310000926326us-gaap:RetainedEarningsMember2018-12-310000926326us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-3100009263262018-12-310000926326us-gaap:RetainedEarningsMember2019-01-012019-03-310000926326us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-03-310000926326us-gaap:CommonStockMember2019-01-012019-03-310000926326us-gaap:AdditionalPaidInCapitalMember2019-01-012019-03-310000926326us-gaap:CommonStockMember2019-03-310000926326us-gaap:TreasuryStockMember2019-03-310000926326us-gaap:AdditionalPaidInCapitalMember2019-03-310000926326us-gaap:RetainedEarningsMember2019-03-310000926326us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-03-3100009263262019-03-31omcl:segment0000926326omcl:HardwareAndSoftwareMember2020-01-012020-03-310000926326omcl:HardwareAndSoftwareMember2019-01-012019-03-310000926326omcl:ConsumablesMember2020-01-012020-03-310000926326omcl:ConsumablesMember2019-01-012019-03-310000926326us-gaap:ProductAndServiceOtherMember2020-01-012020-03-310000926326us-gaap:ProductAndServiceOtherMember2019-01-012019-03-310000926326country:US2020-01-012020-03-310000926326country:US2019-01-012019-03-310000926326us-gaap:NonUsMember2020-01-012020-03-310000926326us-gaap:NonUsMember2019-01-012019-03-310000926326us-gaap:InterestRateSwapMember2016-06-30xbrli:pure0000926326us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:InterestRateSwapMember2016-06-300000926326us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310000926326us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-12-310000926326us-gaap:AccumulatedTranslationAdjustmentMember2018-12-310000926326us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2018-12-310000926326us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-03-310000926326us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-01-012020-03-310000926326us-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-03-310000926326us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-01-012019-03-310000926326us-gaap:AccumulatedTranslationAdjustmentMember2020-03-310000926326us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-03-310000926326us-gaap:AccumulatedTranslationAdjustmentMember2019-03-310000926326us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-03-310000926326us-gaap:EquipmentMember2020-03-310000926326us-gaap:EquipmentMember2019-12-310000926326us-gaap:FurnitureAndFixturesMember2020-03-310000926326us-gaap:FurnitureAndFixturesMember2019-12-310000926326us-gaap:LeaseholdsAndLeaseholdImprovementsMember2020-03-310000926326us-gaap:LeaseholdsAndLeaseholdImprovementsMember2019-12-310000926326us-gaap:SoftwareDevelopmentMember2020-03-310000926326us-gaap:SoftwareDevelopmentMember2019-12-310000926326us-gaap:ConstructionInProgressMember2020-03-310000926326us-gaap:ConstructionInProgressMember2019-12-310000926326country:US2020-03-310000926326country:US2019-12-310000926326us-gaap:NonUsMember2020-03-310000926326us-gaap:NonUsMember2019-12-310000926326us-gaap:CustomerRelationshipsMember2020-03-310000926326us-gaap:CustomerRelationshipsMembersrt:MinimumMember2020-01-012020-03-310000926326us-gaap:CustomerRelationshipsMembersrt:MaximumMember2020-01-012020-03-310000926326us-gaap:TechnologyBasedIntangibleAssetsMember2020-03-310000926326us-gaap:TechnologyBasedIntangibleAssetsMembersrt:MinimumMember2020-01-012020-03-310000926326srt:MaximumMemberus-gaap:TechnologyBasedIntangibleAssetsMember2020-01-012020-03-310000926326us-gaap:OrderOrProductionBacklogMember2020-03-310000926326us-gaap:OrderOrProductionBacklogMember2020-01-012020-03-310000926326us-gaap:TradeNamesMember2020-03-310000926326us-gaap:TradeNamesMembersrt:MinimumMember2020-01-012020-03-310000926326srt:MaximumMemberus-gaap:TradeNamesMember2020-01-012020-03-310000926326us-gaap:PatentsMember2020-03-310000926326us-gaap:PatentsMembersrt:MinimumMember2020-01-012020-03-310000926326srt:MaximumMemberus-gaap:PatentsMember2020-01-012020-03-310000926326us-gaap:CustomerRelationshipsMember2019-12-310000926326us-gaap:CustomerRelationshipsMembersrt:MinimumMember2019-01-012019-12-310000926326us-gaap:CustomerRelationshipsMembersrt:MaximumMember2019-01-012019-12-310000926326us-gaap:TechnologyBasedIntangibleAssetsMember2019-12-310000926326us-gaap:TechnologyBasedIntangibleAssetsMembersrt:MinimumMember2019-01-012019-12-310000926326srt:MaximumMemberus-gaap:TechnologyBasedIntangibleAssetsMember2019-01-012019-12-310000926326us-gaap:OrderOrProductionBacklogMember2019-12-310000926326us-gaap:OrderOrProductionBacklogMember2019-01-012019-12-310000926326us-gaap:TradeNamesMember2019-12-310000926326us-gaap:TradeNamesMembersrt:MinimumMember2019-01-012019-12-310000926326srt:MaximumMemberus-gaap:TradeNamesMember2019-01-012019-12-310000926326us-gaap:PatentsMember2019-12-310000926326us-gaap:PatentsMembersrt:MinimumMember2019-01-012019-12-310000926326srt:MaximumMemberus-gaap:PatentsMember2019-01-012019-12-310000926326us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberomcl:WellsFargoBankNationalAssociationMember2016-01-050000926326us-gaap:LineOfCreditMemberomcl:WellsFargoBankNationalAssociationMemberus-gaap:RevolvingCreditFacilityMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMemberomcl:WellsFargoBankNationalAssociationMemberus-gaap:RevolvingCreditFacilityMember2016-01-050000926326us-gaap:LineOfCreditMemberomcl:TermLoanFacilityMemberomcl:WellsFargoBankNationalAssociationMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMemberomcl:TermLoanFacilityMemberomcl:WellsFargoBankNationalAssociationMember2016-01-050000926326us-gaap:LetterOfCreditMemberomcl:WellsFargoBankNationalAssociationMember2016-01-050000926326omcl:WellsFargoBankNationalAssociationMemberus-gaap:BridgeLoanMember2016-01-050000926326us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberomcl:WellsFargoBankNationalAssociationMemberus-gaap:LondonInterbankOfferedRateLIBORMembersrt:MinimumMemberomcl:CreditAgreementInterestRateOptionOneMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMembersrt:MaximumMemberus-gaap:SecuredDebtMemberomcl:WellsFargoBankNationalAssociationMemberus-gaap:LondonInterbankOfferedRateLIBORMemberomcl:CreditAgreementInterestRateOptionOneMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMemberomcl:CreditAgreementInterestRateOptionTwoMemberus-gaap:SecuredDebtMemberomcl:WellsFargoBankNationalAssociationMemberus-gaap:FederalFundsEffectiveSwapRateMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMemberomcl:CreditAgreementInterestRateOptionTwoMemberus-gaap:SecuredDebtMemberomcl:WellsFargoBankNationalAssociationMemberus-gaap:LondonInterbankOfferedRateLIBORMembersrt:MinimumMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMembersrt:MaximumMemberomcl:CreditAgreementInterestRateOptionTwoMemberus-gaap:SecuredDebtMemberomcl:WellsFargoBankNationalAssociationMemberus-gaap:LondonInterbankOfferedRateLIBORMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMemberomcl:WellsFargoBankNationalAssociationMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMembersrt:MaximumMemberomcl:WellsFargoBankNationalAssociationMemberus-gaap:RevolvingCreditFacilityMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMemberomcl:WellsFargoBankNationalAssociationMemberus-gaap:RevolvingCreditFacilityMember2017-12-260000926326omcl:WellsFargoBankNationalAssociationMember2017-12-012017-12-310000926326us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember2019-11-150000926326us-gaap:LineOfCreditMemberomcl:IncrementalLoanFacilityMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember2019-11-150000926326us-gaap:LineOfCreditMemberus-gaap:LetterOfCreditMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember2019-11-150000926326us-gaap:LineOfCreditMemberus-gaap:BridgeLoanMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember2019-11-150000926326us-gaap:LineOfCreditMemberomcl:TermLoanFacilityMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberus-gaap:LondonInterbankOfferedRateLIBORMembersrt:MinimumMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMembersrt:MaximumMemberus-gaap:LondonInterbankOfferedRateLIBORMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberus-gaap:FederalFundsEffectiveSwapRateMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberus-gaap:LondonInterbankOfferedRateLIBORMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberomcl:LondonInterbankOfferingRateLIBORPlus100Membersrt:MinimumMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMembersrt:MaximumMemberomcl:LondonInterbankOfferingRateLIBORPlus100Memberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMembersrt:MinimumMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMembersrt:MaximumMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMember2019-11-012019-11-300000926326srt:MinimumMember2020-03-310000926326srt:MaximumMember2020-03-310000926326omcl:LeaseReceivableMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-03-310000926326us-gaap:StockCompensationPlanMember2020-01-012020-03-310000926326us-gaap:StockCompensationPlanMember2019-01-012019-03-310000926326us-gaap:CostOfSalesMember2020-01-012020-03-310000926326us-gaap:CostOfSalesMember2019-01-012019-03-310000926326us-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-03-310000926326us-gaap:ResearchAndDevelopmentExpenseMember2019-01-012019-03-310000926326us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-03-310000926326us-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-03-310000926326us-gaap:EmployeeStockOptionMember2020-01-012020-03-310000926326us-gaap:EmployeeStockOptionMember2019-01-012019-03-310000926326us-gaap:EmployeeStockMemberomcl:A1997EmployeeStockPurchasePlanMembersrt:MinimumMember2020-01-012020-03-310000926326srt:MaximumMemberus-gaap:EmployeeStockMemberomcl:A1997EmployeeStockPurchasePlanMember2020-01-012020-03-310000926326us-gaap:EmployeeStockMemberomcl:A1997EmployeeStockPurchasePlanMembersrt:MinimumMember2019-01-012019-03-310000926326srt:MaximumMemberus-gaap:EmployeeStockMemberomcl:A1997EmployeeStockPurchasePlanMember2019-01-012019-03-310000926326us-gaap:EmployeeStockMemberomcl:A1997EmployeeStockPurchasePlanMember2020-01-012020-03-310000926326us-gaap:EmployeeStockMemberomcl:A1997EmployeeStockPurchasePlanMember2019-01-012019-03-310000926326us-gaap:EmployeeStockOptionMemberomcl:A2009PlanMember2019-12-310000926326us-gaap:EmployeeStockOptionMemberomcl:A2009PlanMember2019-01-012019-12-310000926326us-gaap:EmployeeStockOptionMemberomcl:A2009PlanMember2020-01-012020-03-310000926326us-gaap:EmployeeStockOptionMemberomcl:A2009PlanMember2020-03-310000926326us-gaap:EmployeeStockOptionMemberomcl:A2009PlanMember2019-01-012019-03-310000926326us-gaap:EmployeeStockMemberomcl:A1997EmployeeStockPurchasePlanMember2020-03-310000926326us-gaap:RestrictedStockUnitsRSUMemberomcl:A2009PlanMember2019-12-310000926326us-gaap:RestrictedStockUnitsRSUMemberomcl:A2009PlanMember2019-01-012019-12-310000926326us-gaap:RestrictedStockUnitsRSUMemberomcl:A2009PlanMember2020-01-012020-03-310000926326us-gaap:RestrictedStockUnitsRSUMemberomcl:A2009PlanMember2020-03-310000926326us-gaap:RestrictedStockMemberomcl:A2009PlanMember2019-12-310000926326us-gaap:RestrictedStockMemberomcl:A2009PlanMember2020-01-012020-03-310000926326us-gaap:RestrictedStockMemberomcl:A2009PlanMember2020-03-310000926326us-gaap:PerformanceSharesMemberomcl:A2009PlanMember2019-12-310000926326us-gaap:PerformanceSharesMemberomcl:A2009PlanMember2020-01-012020-03-310000926326us-gaap:PerformanceSharesMemberomcl:A2009PlanMember2020-03-310000926326us-gaap:EmployeeStockOptionMember2020-03-310000926326omcl:RestrictedStockAwardsRSAsAndRestrictedStockUnitsRSUsMember2020-03-310000926326omcl:FuturegrantsandawardsMember2020-03-310000926326us-gaap:EmployeeStockMember2020-03-310000926326omcl:The2016RepurchaseProgramMember2016-08-020000926326omcl:A2016and2014ShareRepurchaseProgramsMember2020-03-310000926326omcl:DistributionAgreementMember2017-11-032017-11-030000926326omcl:DistributionAgreementMember2019-01-012019-03-310000926326omcl:DistributionAgreementMember2019-03-310000926326omcl:DistributionAgreementMember2020-03-31
Table of Contents

Washington, D.C. 20549
(Mark One)
For the quarterly period ended March 31, 2020
For the transition period from                  to                
Commission File No. 000-33043
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of
incorporation or organization)
(IRS Employer
Identification No.)
590 East Middlefield Road
Mountain View, CA 94043
(Address of registrant’s principal executive offices, including zip code)

(Registrant’s telephone number, including area code)
        Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, $0.001 par valueOMCLNASDAQ Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý    No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ý    No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated FilerAccelerated filerNon-accelerated filerSmaller reporting companyEmerging growth company
              If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transitions period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes     No ý
As of May 1, 2020, there were 42,619,693 shares of the registrant’s common stock, $0.001 par value, outstanding.

Table of Contents


Table of Contents
March 31,
December 31,
(In thousands, except par value)
Current assets:
Cash and cash equivalents$104,080  $127,210  
Accounts receivable and unbilled receivables, net of allowances of $3,869 and $3,227, respectively
233,068  218,362  
Inventories112,785  108,011  
Prepaid expenses14,155  14,478  
Other current assets14,235  15,177  
Total current assets478,323  483,238  
Property and equipment, net52,997  54,246  
Long-term investment in sales-type leases, net19,992  19,750  
Operating lease right-of-use assets54,376  56,130  
Goodwill334,842  336,539  
Intangible assets, net120,063  124,867  
Long-term deferred tax assets14,142  14,142  
Prepaid commissions45,981  48,862  
Other long-term assets110,931  103,036  
Total assets$1,231,647  $1,240,810  
Current liabilities:
Accounts payable$46,788  $46,380  
Accrued compensation34,990  44,155  
Accrued liabilities58,060  55,567  
Deferred revenues, net108,602  90,894  
Total current liabilities248,440  236,996  
Long-term deferred revenues6,019  7,083  
Long-term deferred tax liabilities37,810  39,090  
Long-term operating lease liabilities48,851  50,669  
Other long-term liabilities12,027  11,718  
Long-term debt  50,000  
Total liabilities353,147  395,556  
Commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, $0.001 par value, 5,000 shares authorized; no shares issued
Common stock, $0.001 par value, 100,000 shares authorized; 51,751 and 51,277 shares issued; 42,606 and 42,132 shares outstanding, respectively
52  51  
Treasury stock at cost, 9,145 shares outstanding, respectively
(185,074) (185,074) 
Additional paid-in capital807,823  780,931  
Retained earnings269,839  258,792  
Accumulated other comprehensive loss(14,140) (9,446) 
Total stockholders’ equity878,500  845,254  
Total liabilities and stockholders’ equity$1,231,647  $1,240,810  
The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.

Table of Contents
Three Months Ended March 31,
(In thousands, except per share data)
Product revenues$170,073  $145,610  
Services and other revenues59,613  56,907  
Total revenues229,686  202,517  
Cost of revenues:
Cost of product revenues90,272  78,811  
Cost of services and other revenues29,792  26,589  
Total cost of revenues120,064  105,400  
Gross profit109,622  97,117  
Operating expenses:
Research and development18,652  16,078  
Selling, general, and administrative78,819  68,278  
Total operating expenses97,471  84,356  
Income from operations12,151  12,761  
Interest and other income (expense), net(822) (1,410) 
Income before provision for income taxes11,329  11,351  
Provision for income taxes18  8,067  
Net income$11,311  $3,284  
Net income per share:
Basic $0.27  $0.08  
Diluted$0.26  $0.08  
Weighted-average shares outstanding:
Basic42,357  40,692  
Diluted43,621  42,281  
The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.


Table of Contents
Three Months Ended March 31,
(In thousands)
Net income$11,311  $3,284  
Other comprehensive income (loss), net of reclassification adjustments and taxes:
Unrealized losses on interest rate swap contracts  (317) 
Foreign currency translation adjustments(4,694) 669  
Other comprehensive income (loss) (4,694) 352  
Comprehensive income$6,617  $3,636  
The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.

Table of Contents
Common StockTreasury StockAdditional
Paid-In Capital
Accumulated Other
Comprehensive Income (Loss)
(In thousands)
Balances as of December 31, 201951,277  $51  (9,145) $(185,074) $780,931  $258,792  $(9,446) $845,254  
Net income—  —  —  —  —  11,311  —  11,311  
Other comprehensive loss—  —  —  —  —  —  (4,694) (4,694) 
Share-based compensation—  —  —  —  10,659  —  —  10,659  
Issuance of common stock under employee stock plans474  1  —  —  17,658  —  —  17,659  
Tax payments related to restricted stock units—  —  —  —  (1,425) —  —  (1,425) 
Cumulative effect of a change in accounting principle related to credit losses—  —  —  —  —  (264) —  (264) 
Balances as of March 31, 202051,751  $52  (9,145) $(185,074) $807,823  $269,839  $(14,140) $878,500  
Common StockTreasury StockAdditional
Paid-In Capital
Accumulated Other
Comprehensive Income (Loss)
(In thousands)
Balances as of December 31, 201849,480  $50  (9,145) $(185,074) $678,041  $197,454  $(10,854) $679,617  
Net income—  —  —  —  —  3,284  —  3,284  
Other comprehensive income—  —  —  —  —  —  352  352  
At the market equity offering, net of costs243  —  —  —  20,216  —  —  20,216  
Share-based compensation—  —  —  —  8,410  —  —  8,410  
Issuance of common stock under employee stock plans628    —  —  20,526  —  —  20,526  
Tax payments related to restricted stock units—  —  —  —  (1,920) —  —  (1,920) 
Balances as of March 31, 201950,351  $50  (9,145) $(185,074) $725,273  $200,738  $(10,502) $730,485  
The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.

Table of Contents
Three Months Ended March 31,
(In thousands)
Operating Activities
Net income$11,311  $3,284  
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization14,043  12,637  
Loss on disposal of property and equipment  355  
Share-based compensation expense10,659  8,410  
Deferred income taxes(1,149) 3,075  
Amortization of operating lease right-of-use assets2,682  2,602  
Amortization of debt issuance costs241  573  
Changes in operating assets and liabilities:
Accounts receivable and unbilled receivables(16,052) (7,251) 
Inventories(5,734) (2,936) 
Prepaid expenses323  3,652  
Other current assets968  373  
Investment in sales-type leases(268) (2,641) 
Prepaid commissions2,881  2,474  
Other long-term assets(2,844) 5,206  
Accounts payable208  (233) 
Accrued compensation(9,165) (12,604) 
Accrued liabilities2,734  127  
Deferred revenues16,868  7,989  
Operating lease liabilities(2,784) (2,669) 
Other long-term liabilities309  4,074  
Net cash provided by operating activities  25,231  26,497  
Investing Activities
Software development for external use(10,602) (11,717) 
Purchases of property and equipment(3,173) (4,980) 
Net cash used in investing activities  (13,775) (16,697) 
Financing Activities
Repayment of debt and revolving credit facility(50,000) (39,000) 
At the market equity offering, net of offering costs  20,216  
Proceeds from issuances under stock-based compensation plans17,659  20,526  
Employees’ taxes paid related to restricted stock units(1,425) (1,920) 
Net cash used in financing activities  (33,766) (178) 
Effect of exchange rate changes on cash and cash equivalents(820) 430  
Net increase (decrease) in cash and cash equivalents (23,130) 10,052  
Cash and cash equivalents at beginning of period127,210  67,192  
Cash and cash equivalents at end of period$104,080  $77,244  
Supplemental disclosure of non-cash activities
Unpaid purchases of property and equipment$944  $1,454  
Property and equipment transferred to inventory$  $105  
Right-of-use assets obtained in exchange for new operating lease liabilities$792  $431  
 The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.

Table of Contents
Note 1. Organization and Summary of Significant Accounting Policies
Omnicell, Inc. was incorporated in California in 1992 under the name Omnicell Technologies, Inc. and reincorporated in Delaware in 2001 as Omnicell, Inc. The Company’s major products are medication management automation solutions and adherence tools for healthcare systems and pharmacies, which are sold in its principal market, the healthcare industry. The Company’s market is primarily located in the United States and Europe. “Omnicell” or the “Company” collectively refer to Omnicell, Inc. and its subsidiaries.
Basis of Presentation
The accompanying unaudited Condensed Consolidated Financial Statements reflect, in the opinion of management, all adjustments, consisting of normal recurring adjustments and accruals, necessary to present fairly the financial position of the Company as of March 31, 2020 and December 31, 2019, the results of operations and comprehensive income for the three months ended March 31, 2020 and 2019, and cash flows for the three months ended March 31, 2020 and 2019. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) have been condensed or omitted in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and accompanying Notes included in the Company’s annual report on Form 10-K for the year ended December 31, 2019 filed with the SEC on February 26, 2020, except as discussed in the sections entitled “Allowance for Credit Losses” and “Recently Adopted Authoritative Guidance” below. The Company’s results of operations and comprehensive income for the three months ended March 31, 2020 and cash flows for the three months ended March 31, 2020 are not necessarily indicative of results that may be expected for the year ending December 31, 2020, or for any future period.
Principles of Consolidation
The Condensed Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Reclassifications and Adjustments
Certain prior-year amounts have been reclassified to conform with current-period presentation. This reclassification was a change in the presentation of certain items in the disaggregation of product revenues for the three months ended March 31, 2019 in Note 2, Revenues, of the Notes to Condensed Consolidated Financial Statements. This change was not deemed material and was included to conform with current-period classification and presentation.
Use of Estimates
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s Condensed Consolidated Financial Statements and accompanying Notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable, including any potential impacts arising from the novel coronavirus (“COVID-19”) pandemic. Although these estimates are based on management’s best knowledge of current events and actions that may impact the Company in the future, actual results may be different from the estimates.
The Company’s critical accounting policies are those that affect its financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition; accounts receivable and notes receivable from investment in sales-type leases; operating lease right-of-use assets and liabilities; inventory valuation; capitalized software development costs; impairment of goodwill and purchased intangibles; share-based compensation; and accounting for income taxes. As of March 31, 2020, the Company is not aware of any events or circumstances that would require an update to its estimates, judgments, or revisions to the carrying value of its assets or liabilities. Given the uncertainty surrounding the COVID-19 pandemic, events or circumstances may arise that could result in a change in estimates, judgments, or revisions to the carrying value of the Company’s assets or liabilities.
Segment Reporting
The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Company's Chief Operating Decision Maker ("CODM") is its Chief Executive Officer. The CODM

Table of Contents
allocates resources and evaluates the performance of the Company at the consolidated level using information about its revenues, gross profit, income from operations, and other key financial data. All significant operating decisions are based upon an analysis of the Company as one operating segment, which is the same as its reporting segment.
Allowance for Credit Losses
The Company is exposed to credit losses primarily through sales of its products and services, as well as its sales-type leasing arrangements. The Company performs credit evaluations of its customers’ financial condition in order to assess each customer’s ability to pay. These evaluations require significant judgment and are based on a variety of factors including, but not limited to, current economic trends, payment history, and a financial review of the customer. The Company continues to monitor customers’ creditworthiness on an ongoing basis.
The Company maintains an allowance for credit losses for accounts receivable, unbilled receivables, and net investment in sales-type leases based on expected credit losses resulting from the inability of its customers to make required payments. The allowance for credit losses is measured using a loss rate method, considering factors such as customers’ credit risk, historical loss experience, current conditions, and forecasts. The allowance for credit losses is measured on a collective (pool) basis by aggregating customer balances with similar risk characteristics. The Company also records a specific allowance based on an analysis of individual past due balances or customer-specific information, such as a decline in creditworthiness or bankruptcy. Actual collection losses may differ from management’s estimates, and such differences could be material to the Company’s financial position and results of operations.
The allowance for credit losses is presented in the Condensed Consolidated Balance Sheets as a deduction from the respective asset balance. The following table summarizes the Company’s allowance for credit losses by asset type:
March 31,
December 31,
(In thousands)
Allowance for credit losses:  
Accounts receivable and unbilled receivables  $3,869  $3,227  
Long-term unbilled receivables (1)
Net investment in sales-type leases (2)
247  225  
(1) Included in other long-term assets in the Condensed Consolidated Balance Sheets.
(2) Includes both current and long-term portions presented in other current assets and long-term investment in sales-type leases, net, respectively.
Changes in the allowances for credit losses were not significant for the three months ended March 31, 2020 and 2019.
Recently Adopted Authoritative Guidance
In August 2018, the FASB issued ASU 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract, to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company adopted ASU 2018-15 on January 1, 2020 on a prospective basis. The adoption of this guidance did not have a material impact on the Company’s Condensed Consolidated Financial Statements.
In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments, that modifies or replaces existing models for trade and other receivables, debt securities, loans, and certain other financial instruments. For instruments measured at amortized cost, including trade and lease receivables, loans, and held-to-maturity debt securities, the standard replaced the current “incurred loss” approach with an “expected loss” model. Entities are required to estimate expected credit losses over the life of the instrument, considering available relevant information about the collectibility of cash flows, including information about past events, current conditions, and reasonable and supportable forecasts. The Company adopted the new standard on January 1, 2020 using the modified retrospective transition method, which resulted in the recognition of an immaterial cumulative-effect adjustment to retained earnings.

Table of Contents
Recently Issued Authoritative Guidance
There was no recently issued and effective authoritative guidance that is expected to have a material impact on the Company’s Condensed Consolidated Financial Statements through the reporting date.
Note 2. Revenues
Revenue Recognition
The Company earns revenues from sales of its products and related services, which are sold in the healthcare industry, its principal market. The Company’s customer arrangements typically include one or more of the following performance obligations:
Products. Software-enabled equipment that manages and regulates the storage and dispensing of pharmaceuticals, consumable blister cards and packaging equipment and other medical supplies.
Software. Additional software applications that enable incremental functionality of the Company’s equipment or services.
Installation. Installation of equipment as integrated systems at customer sites.
Post-installation technical support. Phone support, on-site service, parts, and access to unspecified software updates and enhancements, if and when available.
Professional services. Other customer services, such as training and consulting.
A portion of the Company’s sales are made to customers who are members of Group Purchasing Organizations (“GPOs”). GPOs are often owned fully or in part by the Company’s customers, and the Company pays fees to the GPO on completed contracts. The Company considers these fees consideration paid to customers and records them as reductions to revenue. Fees to GPOs were $2.9 million and $2.2 million for the three months ended March 31, 2020 and 2019, respectively.
Disaggregation of Revenues
The following table summarizes the Company’s product revenues disaggregated by revenue type for the three months ended March 31, 2020 and 2019:
Three Months Ended March 31,
(In thousands)
Hardware and software$142,433  $118,814  
Consumables23,270  23,707  
Other4,370  3,089  
Total product revenues$170,073  $145,610  
The following table summarizes the Company’s revenues disaggregated by geographic region, which is determined based on customer location, for the three months ended March 31, 2020 and 2019:
Three Months Ended March 31,
(In thousands)
United States$207,734  $180,020  
Rest of world (1)
21,952  22,497  
Total revenues$229,686  $202,517  
(1) No individual country represented more than 10% of total revenues.

Table of Contents
Contract Assets and Contract Liabilities
The following table reflects the Company’s contract assets and contract liabilities:
March 31,
December 31,
(In thousands)
Short-term unbilled receivables, net (1)
$10,048  $11,707  
Long-term unbilled receivables, net (2)
14,338  12,260  
Total contract assets  $24,386  $23,967  
Short-term deferred revenues, net  $108,602  $90,894  
Long-term deferred revenues  6,019  7,083  
Total contract liabilities  $114,621  $97,977  
(1) Included in accounts receivable and unbilled receivables in the Condensed Consolidated Balance Sheets.
(2) Included in other long-term assets in the Condensed Consolidated Balance Sheets.
The portion of the transaction price allocated to the Company’s unsatisfied performance obligations for which invoicing has occurred is recorded as deferred revenues.
Short-term deferred revenues of $108.6 million and $90.9 million include deferred revenues from product sales and service contracts, net of deferred cost of sales of $15.4 million and $13.1 million, as of March 31, 2020 and December 31, 2019, respectively. The short-term deferred revenues from product sales relate to delivered and invoiced products, pending installation and acceptance, expected to occur within the next twelve months. During the three months ended March 31, 2020, the Company recognized revenues of $43.4 million that were included in the corresponding gross short-term deferred revenues balance of $104.0 million as of December 31, 2019.
Long-term deferred revenues include deferred revenues from service contracts of $6.0 million and $7.1 million as of March 31, 2020 and December 31, 2019, respectively. Remaining performance obligations primarily relate to maintenance contracts and are recognized ratably over the remaining term of the contract, generally not more than five years.
Significant Customers
There were no customers that accounted for more than 10% of the Company’s total revenues for the three months ended March 31, 2020 and 2019. Also, there were no customers that accounted for more than 10% of the Company’s accounts receivable balance as of March 31, 2020 and December 31, 2019.
Note 3. Net Income Per Share
Basic net income per share is computed by dividing net income for the period by the weighted-average number of shares outstanding during the period. In periods of net loss, all potential common shares are anti-dilutive, so diluted net loss per share equals the basic net loss per share. In periods of net income, diluted net income per share is computed by dividing net income for the period by the basic weighted-average number of shares plus any dilutive potential common stock outstanding during the period. Potential common stock includes the effect of outstanding dilutive stock options, restricted stock awards, and restricted stock units computed using the treasury stock method. Any anti-dilutive weighted-average dilutive shares related to stock award plans are excluded from the computation of the diluted net income per share.

Table of Contents
The basic and diluted net income per share calculations for the three months ended March 31, 2020 and 2019 were as follows:
Three Months Ended March 31,
(In thousands, except per share data)
Net income$11,311  $3,284  
Weighted-average shares outstanding — basic42,357  40,692  
Effect of dilutive securities from stock award plans1,264  1,589  
Weighted-average shares outstanding — diluted43,621  42,281  
Net income per share - basic$0.27  $0.08  
Net income per share - diluted$0.26  $0.08  
Anti-dilutive weighted-average shares related to stock award plans1,744  635  
Note 4. Cash and Cash Equivalents and Fair Value of Financial Instruments
Cash and cash equivalents of $104.1 million and $127.2 million as of March 31, 2020 and December 31, 2019, respectively, consisted of bank accounts with major financial institutions.
Fair Value Hierarchy
The Company measures its financial instruments at fair value. The Company’s cash and cash equivalents are classified within Level 1 of the fair value hierarchy as they are valued primarily using quoted market prices utilizing market observable inputs. The Company's interest rate swap contracts and debt are classified within Level 2 as the valuation inputs are based on quoted prices or market observable data of similar instruments. Refer to Note 8, Debt and Credit Agreements, of the Notes to Condensed Consolidated Financial Statements for further information regarding the Company’s credit facilities.
Interest Rate Swap Contracts
The Company uses interest rate swap agreements to protect the Company against adverse fluctuations in interest rates by reducing its exposure to variability in cash flows relating to interest payments on a portion of its outstanding debt. The Company’s interest rate swaps, which are designated as cash flow hedges, involve the receipt of variable amounts from counterparties in exchange for the Company making fixed-rate payments over the life of the agreements. The Company does not hold or issue any derivative financial instruments for speculative trading purposes.
During 2016, the Company entered into an interest rate swap agreement with a combined notional amount of $100.0 million with one counterparty that became effective on June 30, 2016 and matured on April 30, 2019. The swap agreement required the Company to pay a fixed rate of 0.8% and provided that the Company received a variable rate based on the one month London Interbank Offered Rate (“LIBOR”), subject to a LIBOR floor of 0.0%. Amounts payable by or due to the Company were net settled with the respective counterparty on the last business day of each month, commencing July 31, 2016.

Table of Contents
Note 5. Balance Sheet Components
Balance sheet details as of March 31, 2020 and December 31, 2019 are presented in the tables below:
March 31,
December 31,
(In thousands)
Raw materials  $33,945  $31,331  
Work in process  11,957  7,620  
Finished goods  66,883  69,060  
Total inventories  $112,785  $108,011  
Other long-term assets:
Capitalized software, net  $90,395  $85,070  
Unbilled receivables, net  14,338  12,260  
Deferred debt issuance costs  4,459  4,700  
Other assets  1,739  1,006  
Total other long-term assets  $110,931  $103,036  
Accrued liabilities:
Operating lease liabilities, current portion$9,986  $10,058  
Advance payments from customers6,442  4,006  
Rebates and lease buyouts  15,156  14,911  
Group purchasing organization fees5,382  5,934  
Taxes payable5,974  3,744  
Other accrued liabilities  15,120  16,914  
Total accrued liabilities  $58,060  $55,567  
The following table summarizes the changes in accumulated balances of other comprehensive income (loss) for the three months ended March 31, 2020 and 2019:
Three Months Ended March 31,
Foreign currency translation adjustmentsUnrealized gain (loss) on interest rate swap hedgesTotalForeign currency translation adjustmentsUnrealized gain (loss) on interest rate swap hedgesTotal
(In thousands)
Beginning balance$(9,446) $  $(9,446) $(11,274) $420  $(10,854) 
Other comprehensive income (loss) before reclassifications(4,694)   (4,694) 669  100  769  
Amounts reclassified from other comprehensive income (loss), net of tax        (417) (417) 
Net current-period other comprehensive income (loss), net of tax(4,694)   (4,694) 669  (317) 352  
Ending balance$(14,140) $  $(14,140) $(10,605) $103  $(10,502) 

Table of Contents
Note 6. Property and Equipment
The following table represents the property and equipment balances as of March 31, 2020 and December 31, 2019:
March 31,
December 31,
(In thousands)
Equipment  $90,128  $88,569  
Furniture and fixtures  7,828  7,925  
Leasehold improvements  19,767  18,979  
Software  48,885  48,309  
Construction in progress  6,106  6,179  
Property and equipment, gross  172,714  169,961  
Accumulated depreciation and amortization  (119,717) (115,715) 
Total property and equipment, net  $52,997  $54,246  
Depreciation and amortization expense of property and equipment was $4.3 million and $4.0 million for the three months ended March 31, 2020 and 2019, respectively.
The geographic location of the Company's property and equipment, net, is based on the physical location in which it is located. The following table summarizes the geographic information for property and equipment, net, as of March 31, 2020 and December 31, 2019:
March 31,
December 31,
(In thousands)
United States$47,955  $48,769  
Rest of world (1)
5,042  5,477  
Total property and equipment, net$52,997  $54,246  
(1) No individual country represented more than 10% of total property and equipment, net.
Note 7. Goodwill and Intangible Assets
The following table represents changes in the carrying amount of goodwill:
December 31,
AdditionsForeign currency exchange rate fluctuationsMarch 31,
(In thousands)
Goodwill$336,539  $  $(1,697) $334,842  

Table of Contents
Intangible Assets, Net
The carrying amounts and useful lives of intangible assets as of March 31, 2020 and December 31, 2019 were as follows: